Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>Might a pharmacologic agent that improves insulin resistance be effective in secondary prevention of cardiovascular events?</p>

Pioglitazone and Secondary Cardiovascular Prevention